Project documents | Lumacaftor with ivacaftor for treating cystic fibrosis in children aged 2 to 11 years old homozygous for the F508del mutation [ID1486] | Guidance | NICE

Documents

Documents created during the development process.

Draft scope documents

Draft scope and provisional stakeholder list comments table (post-referral) (MSWord 77 KB)

Published:

22 August 2019
Provisional Stakeholder List (post-referral) (MSWord 78 KB)

Published:

22 August 2019

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral (PDF 320 KB)

Published:

02 October 2018
Draft matrix pre referral (PDF 257 KB)

Published:

02 October 2018